diabetic foot ulcer. Type 2 diabetes mellitus with circulatory complications
Conditions
Interventions
Intervention 1: Intervention Group: For this group, the standard treatment includes debridement and regular dressing along with 1 percent silver sulfadiazine cream combined with 0.001 percent epiderma
Sponsors
Borna Biopharma
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: The age should be 18 years or older and less than 60 years. The patient should have a diabetic foot ulcer classified as grade 1 to 2 according to Wagner classification, with a maximum diameter of 5 centimeters The patient must not have severe vascular diseases, a history of any cancer or tumors, a history of any type of allergy to recombinant growth factors, a history of liver or kidney disease, as well as pregnancy and breastfeeding The patient must have the approval of a specialist physician to participate in the study.
Exclusion criteria
Exclusion criteria: The patient should not have underlying conditions that interfere with wound healing, such as severe vascular diseases, any form of cancer or tumors, and liver or kidney disease during the study. Observation of any type of allergy to the creams used is required Pregnancy during the study period is not allowed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diabetic foot ulcer healing speed. Timepoint: The size of the wounds and their characteristics at the beginning of the study and at each follow-up (weeks 1, 2, 3, 5, and 8 after enrollment) will be recorded by the physician. Method of measurement: In this study, wound healing is evaluated by measuring its area using ImageJ software. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Mehdi Tabaie
Tehran University of Medical Sciences
Outcome results
None listed